Nitroglycerin Use in the Emergency Department: Current Perspectives

Michael J Twiner; John Hennessy; Rachel Wein; Phillip D Levy

doi:10.2147/OAEM.S340513

Nitroglycerin Use in the Emergency Department: Current Perspectives

Open Access Emerg Med. 2022 Jul 9:14:327-333. doi: 10.2147/OAEM.S340513. eCollection 2022.

Authors

Michael J Twiner^{1

2}, John Hennessy³, Rachel Wein¹, Phillip D Levy^{1

2}

Affiliations

¹ Department of Emergency Medicine, Wayne State University, Detroit, MI, USA.
² Integrative Biosciences Center, Wayne State University, Detroit, MI, USA.
³ College of Engineering, University of Michigan, Ann Arbor, MI, USA.

Abstract

Nitroglycerin, a fast-acting vasodilator, is commonly used as a first-line agent for angina in the emergency department and to manage chest pain due to acute coronary syndromes. It is also a treatment option for other disease states such as acute heart failure, pulmonary edema, and aortic dissection. Nitroglycerin is converted to nitric oxide, a potent vasodilator, in the body, leading to venodilation at lower dosages and arteriodilation at higher dosages that results in both preload and afterload reduction, respectively. Although nitroglycerin has historically been administered as a sublingual tablet and/or spray, it is often given intravenously in the emergency department as this enables titration to effect with predictable pharmacokinetics. In this review article, we outline the indications, mechanism of action, contraindications, and adverse effects of nitroglycerin as well as review relevant literature and make general recommendations regarding the use of nitroglycerin in the emergency department.

Keywords: acute coronary syndrome; chest pain; heart failure; hypertensive emergency; nitrates; nitroglycerin; pulmonary edema.

Publication types

Review